BLACKMORES BIO C 500 SUSTAINED RELEASE

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

rutoside, Quantity: 50 mg; ascorbic acid, Quantity: 280 mg; Citrus bioflavonoids extract, Quantity: 25 mg; hesperidin, Quantity: 25 mg; calcium ascorbate dihydrate, Quantity: 266 mg (Equivalent: ascorbic acid, Qty 220 mg); Rosa canina, Quantity: 41.67 mg (Equivalent: Rosa canina, Qty 250 mg)

Commercializzato da:

Blackmores Ltd

Forma farmaceutica:

Tablet, modified release

Composizione:

Excipient Ingredients: purified talc; calcium phosphate; Guar Gum; iron oxide yellow; macrogol 400; tartaric acid; Acacia; hydrogenated vegetable oil; titanium dioxide; magnesium stearate; colloidal anhydrous silica; Carnauba Wax; hypromellose

Via di somministrazione:

Oral

Indicazioni terapeutiche:

Antioxidant/Reduce free radicals formed in the body ; Helps reduce/decrease free radical damage to body cells ; Maintain/support collagen formation ; Maintain/support general health and wellbeing ; Maintain/support blood vessel health ; Maintain/support immune system health ; Maintain/support healthy immune system function ; Maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; Maintain/support (state vitamin/mineral/nutrient) levels in the body ; Decrease/reduce/relieve common cold duration ; Decrease/reduce/relieve the severity of common cold symptoms ; Maintain/support wound healing

Dettagli prodotto:

Visual Identification: ;

Stato dell'autorizzazione:

Listed

Data dell'autorizzazione:

2020-12-14